Interaction of homo-aza-steroidal ester of [p-[bis-(2-chloroethyl) amino]phenyl]acetic acid (ASE) with DNA of Ehrlich ascites tumor cells. 1983

A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos

A cytostatic, homo-aza-steroidal ester of [p-[bis-(2-chloroethyl) amino]phenyl]acetic acid (ASE) was reduced with NaB3H4 and [3H]ASE-treated DNA prepared in vitro. We found that: (1) ASE reacts preferentially with purines; (2) ASE decreases the thermal stability of the double helix upon binding to DNA; (3) [3H]ASE binding sites are clustered along the DNA molecules; (4) ASE binding sites probably represent oligo- or polypurine sequences.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009588 Nitrogen Mustard Compounds A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens. Compounds, Nitrogen Mustard,Mustard Compounds, Nitrogen
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D001894 Borohydrides A class of inorganic or organic compounds that contain the borohydride (BH4-) anion. Borohydride
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot

Related Publications

A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
January 1984, Methods and findings in experimental and clinical pharmacology,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
January 1977, Cancer treatment reports,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
January 1983, Cancer chemotherapy and pharmacology,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
January 1973, Cancer chemotherapy reports,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
July 1978, Journal of steroid biochemistry,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
January 1983, Environmental mutagenesis,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
January 2001, Cancer detection and prevention,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
January 1993, Anticancer research,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
December 1993, Mutation research,
A Papageorgiou, and I G Ivanov, and G G Markov, and S I Koliais, and L Boutis, and P Catsoulakos
November 1990, Journal of pharmaceutical sciences,
Copied contents to your clipboard!